Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCI | P41743 | 1/20 | 0.32 |
| ▸ | ATR | Q13535 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24023378 | 0.87 | PLCG1 (0.40) | PRKCIALDH1A1LMNANPC1RAB9A | |
| SCHEMBL14865813 | 0.76 | PRKCI (0.41) | PRKCIALDH1A1LMNANPC1RAB9A | |
| SCHEMBL30765197 | 0.74 | SMN1; SMN2 (0.36) | PRKCIALDH1A1SMN1; SMN2 | |
| SCHEMBL23181007 | 0.74 | SMN1; SMN2 (0.36) | PRKCIALDH1A1SMN1; SMN2 | |
| SCHEMBL31696659 | 0.73 | MGLL (0.39) | SMN1; SMN2 | |
| SCHEMBL22086359 | 0.72 | ATR (0.44) | ATR | |
| SCHEMBL23916448 | 0.72 | ENPP2 (0.33) | — | |
| SCHEMBL29953498 | 0.70 | LMNA (0.36) | LMNA | |
| SCHEMBL17816265 | 0.70 | DGAT1 (0.33) | MAPTLMNANPC1RAB9ASMN1; SMN2 | |
| SCHEMBL18342381 | 0.70 | KDM4A (0.41) | ATRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024191268-A1 | NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | 현대약품 주식회사 | 2024-09-19 | — | — | WO | disclosed |